Skip to content

Antibodies against HLA-E-VL9 enhance NK cell and CD8+ T cell cytotoxicity against tumor cells and HIV-infected CD4+ T cells.

Sep 2026 · Science Translational Medicine · Vol 18 867, pp. eaea3879 · 0 citations
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.